Free Trial
NASDAQ:MEIP

MEI Pharma (MEIP) Stock Price, News & Analysis

MEI Pharma logo
$2.64 +0.05 (+1.73%)
As of 11:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MEI Pharma Stock (NASDAQ:MEIP)

Key Stats

Today's Range
$2.64
$2.65
50-Day Range
$2.04
$2.84
52-Week Range
$1.46
$4.10
Volume
433 shs
Average Volume
44,153 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

MEI Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

MEIP MarketRank™: 

MEI Pharma scored higher than 51% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for MEI Pharma are expected to grow in the coming year, from ($5.10) to ($3.71) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MEI Pharma is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MEI Pharma is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MEI Pharma has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MEI Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of MEI Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    MEI Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MEI Pharma has recently decreased by 51.85%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MEI Pharma does not currently pay a dividend.

  • Dividend Growth

    MEI Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of MEI Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    MEI Pharma has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MEI Pharma has recently decreased by 51.85%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, MEI Pharma insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.12% of the stock of MEI Pharma is held by insiders.

    • Percentage Held by Institutions

      52.38% of the stock of MEI Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about MEI Pharma's insider trading history.
    Receive MEIP Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter.

    MEIP Stock News Headlines

    The Trump Dump is starting; Get out of stocks now?
    The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
    MEI Pharma Registered Shs
    MEI Pharma (NASDAQ:MEIP) Stock, Option Chain
    See More Headlines

    MEIP Stock Analysis - Frequently Asked Questions

    MEI Pharma's stock was trading at $2.46 at the beginning of 2025. Since then, MEIP shares have increased by 7.5% and is now trading at $2.6450.

    MEI Pharma, Inc. (NASDAQ:MEIP) released its earnings results on Tuesday, May, 13th. The company reported ($0.39) earnings per share for the quarter.

    Shares of MEI Pharma reverse split on Monday, April 17th 2023.The 1-20 reverse split was announced on Monday, April 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

    Shares of MEIP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that MEI Pharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), CymaBay Therapeutics (CBAY) and Jabil (JBL).

    Company Calendar

    Last Earnings
    5/13/2025
    Today
    7/09/2025
    Next Earnings (Estimated)
    9/17/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - DRUGS
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:MEIP
    Previous Symbol
    NASDAQ:MSHL
    CIK
    1262104
    Employees
    100
    Year Founded
    N/A

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    $17.78 million
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $65.30 million
    Cash Flow
    $6.01 per share
    Price / Cash Flow
    0.44
    Book Value
    $4.96 per share
    Price / Book
    0.53

    Miscellaneous

    Free Float
    N/A
    Optionable
    Optionable
    Beta
    0.19

    Social Links

    (Almost)  Everything You Need To Know About The EV Market Cover

    Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

    Get This Free Report

    This page (NASDAQ:MEIP) was last updated on 7/9/2025 by MarketBeat.com Staff
    From Our Partners